Search

Your search keyword '"Kitagawa, Kazuo"' showing total 1,463 results
Start Over Author "Kitagawa, Kazuo"
1,463 results on '"Kitagawa, Kazuo"'

55. Stroke in Patients With Common Noncancerous Gynecologic Diseases

Author

Yamashiro, Kazuo, primary, Sato, Takeo, additional, Nito, Chikako, additional, Ueno, Yuji, additional, Kawano, Hiroyuki, additional, Chiba, Tetsuya, additional, Nishihira, Takahito, additional, Mizuno, Takafumi, additional, Ishizuka, Kentaro, additional, Iguchi, Yasuyuki, additional, Kimura, Kazumi, additional, Kitagawa, Kazuo, additional, Koga, Masatoshi, additional, Hirano, Teruyuki, additional, Kameda, Tomoaki, additional, Takekawa, Hidehiro, additional, Urabe, Takao, additional, Taneichi, Akiyo, additional, Fujiwara, Hiroyuki, additional, Fujimoto, Shigeru, additional, Hattori, Nobutaka, additional, and Tanaka, Ryota, additional

Published
2023
Full Text
View/download PDF

56. Short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE): a multicenter, open-label, randomized clinical trial

Author

Ozaki, Tomohiko, primary, Yamagami, Hiroshi, additional, Morimoto, Masafumi, additional, Hatano, Taketo, additional, Oishi, Hidenori, additional, Haraguchi, Koichi, additional, Yoshimura, Shinichi, additional, Sugiu, Kenji, additional, Iihara, Koji, additional, Matsumaru, Yuji, additional, Matsumoto, Yasushi, additional, Satow, Tetsu, additional, Hayakawa, Mikito, additional, Sakai, Chiaki, additional, Miyamoto, Susumu, additional, Kitagawa, Kazuo, additional, Daimon, Takashi, additional, Kagimura, Tatsuo, additional, and Sakai, Nobuyuki, additional

Published
2023
Full Text
View/download PDF

57. Detection of Atrial Fibrillation Using Insertable Cardiac Monitors in Patients With Cryptogenic Stroke in Japan (the LOOK Study): Protocol for a Prospective Multicenter Observational Study

Author

Suda, Satoshi, primary, Katano, Takehiro, additional, Kitagawa, Kazuo, additional, Iguchi, Yasuyuki, additional, Fujimoto, Shigeru, additional, Ono, Kenjiro, additional, Kano, Osamu, additional, Takekawa, Hidehiro, additional, Koga, Masatoshi, additional, Ihara, Masafumi, additional, Morimoto, Masafumi, additional, Yamagami, Hiroshi, additional, Terasaki, Tadashi, additional, Yamaguchi, Keiji, additional, Okubo, Seiji, additional, Ueno, Yuji, additional, Ohara, Nobuyuki, additional, Kamiya, Yuki, additional, Takeuchi, Masataka, additional, Yazawa, Yukako, additional, Terasawa, Yuka, additional, Doijiri, Ryosuke, additional, Tsuboi, Yoshifumi, additional, Sonoda, Kazutaka, additional, Nomura, Koichi, additional, Shimoyama, Takashi, additional, Kutsuna, Akihito, additional, and Kimura, Kazumi, additional

Published
2023
Full Text
View/download PDF

58. Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment

Author

Seekircher, Lisa, Tschiderer, Lena, Lind, Lars, Safarova, Maya S., Kavousi, Maryam, Ikram, M. Arfan, Lonn, Eva, Yusuf, Salim, Grobbee, Diederick E., Kastelein, John J.P., Visseren, Frank L.J., Walters, Matthew, Dawson, Jesse, Higgins, Peter, Agewall, Stefan, Catapano, Alberico, De Groot, Eric, Espeland, Mark A., Klingenschmid, Gerhard, Magliano, Dianna, Olsen, Michael H., Preiss, David, Sander, Dirk, Skilton, Michael, Zozulińska-Ziółkiewicz, Dorota A., Grooteman, Muriel P.C., Blankestijn, Peter J., Kitagawa, Kazuo, Okazaki, Shuhei, Manzi, Maria V., Mancusi, Costantino, Izzo, Raffaele, Desvarieux, Moise, Rundek, Tatjana, Gerstein, Hertzel C., Bots, Michiel L., Sweeting, Michael J., Lorenz, Matthias W., Willeit, Peter, Seekircher, Lisa, Tschiderer, Lena, Lind, Lars, Safarova, Maya S., Kavousi, Maryam, Ikram, M. Arfan, Lonn, Eva, Yusuf, Salim, Grobbee, Diederick E., Kastelein, John J.P., Visseren, Frank L.J., Walters, Matthew, Dawson, Jesse, Higgins, Peter, Agewall, Stefan, Catapano, Alberico, De Groot, Eric, Espeland, Mark A., Klingenschmid, Gerhard, Magliano, Dianna, Olsen, Michael H., Preiss, David, Sander, Dirk, Skilton, Michael, Zozulińska-Ziółkiewicz, Dorota A., Grooteman, Muriel P.C., Blankestijn, Peter J., Kitagawa, Kazuo, Okazaki, Shuhei, Manzi, Maria V., Mancusi, Costantino, Izzo, Raffaele, Desvarieux, Moise, Rundek, Tatjana, Gerstein, Hertzel C., Bots, Michiel L., Sweeting, Michael J., Lorenz, Matthias W., and Willeit, Peter

Abstract

Aims: Current guidelines recommend measuring carotid intima-media thickness (IMT) at the far wall of the common carotid artery (CCA). We aimed to precisely quantify associations of near vs. far wall CCA-IMT with the risk for atherosclerotic cardiovascular disease (CVD, defined as coronary heart disease or stroke) and their added predictive values. Methods and results: We analysed individual records of 41 941 participants from 16 prospective studies in the Proof-ATHERO consortium {mean age 61 years [standard deviation (SD) = 11]; 53% female; 16% prior CVD}. Mean baseline values of near and far wall CCA-IMT were 0.83 (SD = 0.28) and 0.82 (SD = 0.27) mm, differed by a mean of 0.02 mm (95% limits of agreement: -0.40 to 0.43), and were moderately correlated [r = 0.44; 95% confidence interval (CI): 0.39-0.49). Over a median follow-up of 9.3 years, we recorded 10 423 CVD events. We pooled study-specific hazard ratios for CVD using random-effects meta-analysis. Near and far wall CCA-IMT values were approximately linearly associated with CVD risk. The respective hazard ratios per SD higher value were 1.18 (95% CI: 1.14-1.22; I² = 30.7%) and 1.20 (1.18-1.23; I² = 5.3%) when adjusted for age, sex, and prior CVD and 1.09 (1.07-1.12; I² = 8.4%) and 1.14 (1.12-1.16; I²=1.3%) upon multivariable adjustment (all P < 0.001). Assessing CCA-IMT at both walls provided a greater C-index improvement than assessing CCA-IMT at one wall only [+0.0046 vs. +0.0023 for near (P < 0.001), +0.0037 for far wall (P = 0.006)]. Conclusions: The associations of near and far wall CCA-IMT with incident CVD were positive, approximately linear, and similarly strong. Improvement in risk discrimination was highest when CCA-IMT was measured at both walls.

Published
2023

59. Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment

Author

Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Interne Geneeskunde Vasculaire, Nefro Vasculaire Geneeskunde, Cardiovasculaire Epi Team 5, Cardiovasculaire Epidemiologie, Seekircher, Lisa, Tschiderer, Lena, Lind, Lars, Safarova, Maya S., Kavousi, Maryam, Ikram, M. Arfan, Lonn, Eva, Yusuf, Salim, Grobbee, Diederick E., Kastelein, John J.P., Visseren, Frank L.J., Walters, Matthew, Dawson, Jesse, Higgins, Peter, Agewall, Stefan, Catapano, Alberico, De Groot, Eric, Espeland, Mark A., Klingenschmid, Gerhard, Magliano, Dianna, Olsen, Michael H., Preiss, David, Sander, Dirk, Skilton, Michael, Zozulińska-Ziółkiewicz, Dorota A., Grooteman, Muriel P.C., Blankestijn, Peter J., Kitagawa, Kazuo, Okazaki, Shuhei, Manzi, Maria V., Mancusi, Costantino, Izzo, Raffaele, Desvarieux, Moise, Rundek, Tatjana, Gerstein, Hertzel C., Bots, Michiel L., Sweeting, Michael J., Lorenz, Matthias W., Willeit, Peter, Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Interne Geneeskunde Vasculaire, Nefro Vasculaire Geneeskunde, Cardiovasculaire Epi Team 5, Cardiovasculaire Epidemiologie, Seekircher, Lisa, Tschiderer, Lena, Lind, Lars, Safarova, Maya S., Kavousi, Maryam, Ikram, M. Arfan, Lonn, Eva, Yusuf, Salim, Grobbee, Diederick E., Kastelein, John J.P., Visseren, Frank L.J., Walters, Matthew, Dawson, Jesse, Higgins, Peter, Agewall, Stefan, Catapano, Alberico, De Groot, Eric, Espeland, Mark A., Klingenschmid, Gerhard, Magliano, Dianna, Olsen, Michael H., Preiss, David, Sander, Dirk, Skilton, Michael, Zozulińska-Ziółkiewicz, Dorota A., Grooteman, Muriel P.C., Blankestijn, Peter J., Kitagawa, Kazuo, Okazaki, Shuhei, Manzi, Maria V., Mancusi, Costantino, Izzo, Raffaele, Desvarieux, Moise, Rundek, Tatjana, Gerstein, Hertzel C., Bots, Michiel L., Sweeting, Michael J., Lorenz, Matthias W., and Willeit, Peter

Published
2023

61. Stroke

Author

Kitagawa, Kazuo, Wakabayashi, Ichiro, editor, and Groschner, Klaus, editor

Published
2014
Full Text
View/download PDF

63. Short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE): a multicenter, open-label, randomized clinical trial

Author

Ozaki, Tomohiko, Yamagami, Hiroshi, Morimoto, Masafumi, Hatano, Taketo, Oishi, Hidenori, Haraguchi, Koichi, Yoshimura, Shinichi, Sugiu, Kenji, Iihara, Koji, Matsumaru, Yuji, Matsumoto, Yasushi, Satow, Tetsu, Hayakawa, Mikito, Sakai, Chiaki, Miyamoto, Susumu, Kitagawa, Kazuo, Daimon, Takashi, Kagimura, Tatsuo, and Sakai, Nobuyuki

Abstract

BackgroundThe optimal duration of dual antiplatelet therapy (DAPT) after stent-assisted coil embolization (SACE) for cerebral aneurysm remains uncertain. This randomized trial of short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE) aimed to clarify whether long-term DAPT can reduce the occurrence of ischemic stroke in patients with cerebral aneurysms treated by SACE compared with short-term DAPT.MethodsPatients treated for cerebral aneurysm with SACE were enrolled from 17 hospitals in Japan. Patients were enrolled within 30 days after SACE and assigned in a 1:1 ratio to receive long-term (12 months) or short-term (3 months) DAPT with aspirin and clopidogrel. Randomization was performed centrally through a web-based system. The primary outcome was the time to ischemic stroke event during 3 to 12 months after SACE. This trial was registered with the Japan Registry of Clinical Trials (jRCTs051180141).ResultsA total of 142 patients were recruited from November 4, 2016 to January 7, 2019. Among them, 65 and 68 patients assigned to the long- and short-term DAPT groups, respectively, were included in the full analysis set. Ischemic stroke occurred in no patients in the long-term DAPT group and in one patient in the short-term DAPT group. The incidence rate did not differ between the groups (0.0 vs 2.1/100 person-years; log rank test, P=0.33).ConclusionsIn this multicenter randomized controlled trial, there was not a statistically significant difference in the rate of ischemic strokes between long- and short-term DAPT.

Published
2024
Full Text
View/download PDF

64. Relation between duration of dual antiplatelet therapy and risk of ischemic stroke after stent-assisted treatment of cerebral aneurysm (DAPTS ACE-registry)

Author

Ozaki, Tomohiko, Yamagami, Hiroshi, Morimoto, Masafumi, Imamura, Hirotoshi, Hatano, Taketo, Oishi, Hidenori, Haraguchi, Koichi, Yoshimura, Shinichi, Satow, Tetsu, Sugiu, Kenji, Iihara, Koji, Matsumaru, Yuji, Hayakawa, Mikito, Matsumoto, Yasushi, Sakai, Chiaki, Miyamoto, Susumu, Kitagawa, Kazuo, Kagimura, Tatsuo, and Sakai, Nobuyuki

Abstract

BackgroundThe optimal duration of dual antiplatelet therapy (DAPT) in patients with cerebral aneurysm who undergo stent-assisted coil embolization (SACE) has not been established. We aimed to clarify the association between duration of DAPT and incidence of ischemic stroke in patients with cerebral aneurysm.MethodsWe registered patients with cerebral aneurysm who underwent SACE in 27 hospitals in Japan. Those treated with DAPT (aspirin and clopidogrel) were eligible for inclusion in a previously reported randomized control trial (RCT). Patients who were ineligible or refused to participate to the RCT were followed-up for 15 months after SACE as the non-RCT cohort. Our study examined both the RCT and non-RCT cohorts. The primary and secondary outcomes were ischemic stroke and hemorrhagic events.ResultsAmong the 313 patients registered, 296 were included for analysis (of these, 136 were RCT patients and 160 were non-RCT patients). Patients who were treated with DAPT for more than 6 months (n=191) were classified as the long-term DAPT group. Those treated less than 6 months (n=105) were classified as the short-term group. The incidence of ischemic stroke did not significantly differ between the long-term group (2.5 per 100 person-years) and the short-term group (3.2 per 100 person-years); nor did incidence of hemorrhagic events (0.8 and 3.2 per 100 person-years, respectively). The period of DAPT was not significantly associated with incidence rates of ischemic stroke or hemorrhagic events.ConclusionsDuration of DAPT was not associated with the incidence of ischemic stroke in the first 15 months after SACE.

Published
2024
Full Text
View/download PDF

67. Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy

Author

Zhang, Xu, primary, Kira, Jun-Ichi, additional, Ogata, Hidenori, additional, Imamura, Tomohiro, additional, Mitsuishi, Mikio, additional, Fujii, Takayuki, additional, Kobayashi, Masaki, additional, Kitagawa, Kazuo, additional, Namihira, Yukihiro, additional, Ohya, Yusuke, additional, Maimaitijiang, Guzailiayi, additional, Yamasaki, Ryo, additional, Fukata, Yuko, additional, Fukata, Masaki, additional, Isobe, Noriko, additional, and Nakamura, Yuri, additional

Published
2023
Full Text
View/download PDF

72. Subsequent Vascular Events after Ischemic Stroke: The Japan Statin Treatment against Recurrent Stroke—Longitudinal

Author

Nomura, Eiichi, Suzuki, Akifumi, Inoue, Isao, Nakagawara, Jyoji, Takahashi, Kazuo, Takahashi, Tetsuya, Manabe, Yasuhiro, Yokota, Chiaki, Okada, Kazunori, Nishihara, Tetsuhiro, Yamamoto, Yasumasa, Noda, Koichi, Takahashi, Shinichi, Ibayashi, Setsuro, Takagi, Makoto, Kitagawa, Kazuo, Tanahashi, Norio, Kuriyama, Masaru, Hirata, Koichi, Hosomi, Naohisa, Minematsu, Kazuo, Kobayashi, Shotai, and Matsumoto, Masayasu

Published
2015
Full Text
View/download PDF

76. IgG4 ‐related brain pseudotumor mimicking CNS lymphoma. A case report

Author

Oshima, Rie, primary, Ikeguchi, Ryotaro, additional, Wako, Sho, additional, Mizuno, Takafumi, additional, Abe, Kayoko, additional, Nitta, Masayuki, additional, Muragaki, Yoshihiro, additional, Kawamata, Takakazu, additional, Masui, Kenta, additional, Yamamoto, Tomoko, additional, Shibata, Noriyuki, additional, Shimizu, Yuko, additional, and Kitagawa, Kazuo, additional

Published
2022
Full Text
View/download PDF

78. Relationship Between Magnetic Resonance Angiography–Diffusion-weighted Imaging Mismatch and Clinical Outcome in Endovascular Treatment for Acute Ischemic Stroke: Subgroup Analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism–Japan Registry

Author

Deguchi, Ichiro, Dembo, Tomohisa, Yoshimura, Shinichi, Sakai, Nobuyuki, Okada, Yasushi, Kitagawa, Kazuo, Kimura, Kazumi, Hyogo, Toshio, Yamagami, Hiroshi, Egashira, Yusuke, and Tanahashi, Norio

Published
2014
Full Text
View/download PDF

80. Long-Term Effect of Pravastatin on Carotid Intima–Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke)

Author

Koga, Masatoshi, Toyoda, Kazunori, Minematsu, Kazuo, Yasaka, Masahiro, Nagai, Yoji, Aoki, Shiro, Nezu, Tomohisa, Hosomi, Naohisa, Kagimura, Tatsuo, Origasa, Hideki, Kamiyama, Kenji, Suzuki, Rieko, Ohtsuki, Toshiho, Maruyama, Hirofumi, Kitagawa, Kazuo, Uchiyama, Shinichiro, and Matsumoto, Masayasu

Published
2018
Full Text
View/download PDF

81. Remote ischemic conditioning for acute ischemic stroke part 2: Study protocol for a randomized controlled trial

Author

Ishizuka, Kentaro, primary, Hoshino, Takao, additional, Toi, Sono, additional, Mizuno, Takafumi, additional, Hosoya, Megumi, additional, Saito, Moeko, additional, Sato, Yasuto, additional, Yagita, Yoshiki, additional, Todo, Kenichi, additional, Sakaguchi, Manabu, additional, Ohashi, Takashi, additional, Maruyama, Kenji, additional, Hino, Shuji, additional, Honma, Yutaka, additional, Doijiri, Ryosuke, additional, Yamagami, Hiroshi, additional, Iguchi, Yasuyuki, additional, Hirano, Teruyuki, additional, Kimura, Kazumi, additional, Kitazono, Takanari, additional, and Kitagawa, Kazuo, additional

Published
2022
Full Text
View/download PDF

85. Imaging Characteristics for Predicting Cognitive Impairment in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy

Author

Taniguchi, Akira, primary, Shindo, Akihiro, additional, Tabei, Ken-ichi, additional, Onodera, Osamu, additional, Ando, Yukio, additional, Urabe, Takao, additional, Kimura, Kazumi, additional, Kitagawa, Kazuo, additional, Miyamoto, Yoshihiro, additional, Takegami, Misa, additional, Ihara, Masafumi, additional, Mizuta, Ikuko, additional, Mizuno, Toshiki, additional, and Tomimoto, Hidekazu, additional

Published
2022
Full Text
View/download PDF

89. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial.

Author

Uchiyama, Shinichiro, Toyoda, Kazunori, Okamura, Satomi, Omae, Katsuhiro, Hoshino, Haruhiko, Kimura, Kazumi, Kitagawa, Kazuo, Minematsu, Kazuo, and Yamaguchi, Takenori

Subjects
ARTERIAL stenosis, PLATELET aggregation inhibitors, STROKE patients, SUBGROUP analysis (Experimental design), ISCHEMIC stroke
Abstract

Background: We previously reported that dual antiplatelet therapy (DAPT) with cilostazol was superior to aspirin or clopidogrel for the prevention of recurrent stroke and vascular events in a subgroup analysis of intracranial arterial stenosis in the Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com), a randomized controlled trial. Aims: We conducted another subgroup analysis to investigate the benefit of DAPT with cilostazol in patients with extracranial arterial stenosis (ECAS) and those without arterial stenosis. Methods: We compared the risk of recurrent ischemic stroke, vascular events, and major bleeding between DAPT with cilostazol plus aspirin or clopidogrel and aspirin or clopidogrel alone in patients with ischemic stroke between 8 and 180 days before starting trial treatment and ECAS or without arterial stenosis. Results: The median follow-up period was 1.4 years. The risk of recurrent ischemic stroke (hazard ratio (HR): 1.04, 95% confidence interval (CI): 0.42–2.57) and vascular events (HR: 0.97, 95% CI: 0.42–2.24) did not differ between the two groups for the 253 patients with ECAS, whereas they were lower (HR: 0.36, 95% CI: 0.18–0.74 and HR: 0.47, 95% CI: 0.26–0.85, respectively) in the DAPT group for the 944 patients without arterial stenosis. The risk of major bleeding did not differ between the groups in patients with ECAS (HR: 0.58, 95% CI: 0.05–6.39) or without arterial stenosis (HR: 0.79, 95% CI: 0.27–2.26). Conclusion: DAPT with cilostazol might be beneficial for prevention of recurrent stroke and vascular events in patients without arterial stenosis but not in those with ECAS. Data access statement: We will make the deidentified participant data from this research available to the scientific community with as few restrictions as feasible, while retaining exclusive use until the publication of major output. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

90. Reclassification and risk stratification of embolic stroke of undetermined source by ASCOD phenotyping.

Author

Hoshino, Takao, Mizuno, Takafumi, Nishimura, Ayako, Ishizuka, Kentaro, Toi, Sono, Takahashi, Shuntaro, Wako, Sho, and Kitagawa, Kazuo

Subjects
STROKE, ACUTE coronary syndrome, PROGNOSIS, MAGNETIC resonance imaging, THORACIC aorta, MYOCARDIAL infarction, ATHEROSCLEROTIC plaque
Abstract

Background: Common vascular diseases underlying stroke, including atherosclerosis, small-vessel disease (SVD), and cardioembolic pathology, can be present in patients with embolic stroke of undetermined source (ESUS), although these are not direct causes of stroke. Aims: To describe the frequency and degree of the three major diseases using atherosclerosis, SVD, cardiac pathology, other causes, and dissection (ASCOD) phenotyping and to assess their prognostic implications in ESUS. Methods: In this prospective observational study, 221 patients with ESUS within 1 week of onset were consecutively enrolled and followed up for 1 year. Vascular diseases associated with stroke were assessed using the ASCOD classification. The primary outcome was a composite of nonfatal stroke, nonfatal acute coronary syndrome, and vascular death. Results: Among 221 patients (mean age, 69.6 years; male, 59.7%), 135 (61.1%), 102 (46.2%), and 107 (48.4%) had any grade of atherosclerosis (A2 or A3), SVD (S3), and cardiac pathology (C2 or C3), respectively. ESUS patients graded as A2 or A3 (i.e. ipsilateral atherosclerotic plaque, contralateral ⩾ 50% stenosis, or aortic arch plaque) were at a significantly higher risk of composite vascular events than those graded as A0 (i.e. no atherosclerotic disease) (adjusted hazard ratio (95% confidence interval), 2.40 (1.01–5.72). No differences were observed in the event risk between patients with S3 (i.e. magnetic resonance imaging evidence of SVD) and S0 (i.e. no SVD) and between those with C2 or C3 (i.e. presence of any cardiac pathology) and C0 (i.e. no cardiac abnormalities). Conclusions: Atherosclerotic diseases corresponding to ASCOD grade A2 or A3 were predictive of recurrent vascular events in ESUS patients. Reclassification of ESUS using ASCOD phenotyping provides important clues for risk prediction and may guide optimal management strategies. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

94. Detection of Atrial Fibrillation Using Insertable Cardiac Monitors in Patients With Cryptogenic Stroke in Japan (the LOOK Study): Protocol for a Prospective Multicenter Observational Study (Preprint)

Author

Suda, Satoshi, primary, Katano, Takehiro, additional, Kitagawa, Kazuo, additional, Iguchi, Yasuyuki, additional, Fujimoto, Shigeru, additional, Ono, Kenjiro, additional, Kano, Osamu, additional, Takekawa, Hidehiro, additional, Koga, Masatoshi, additional, Ihara, Masafumi, additional, Morimoto, Masafumi, additional, Yamagami, Hiroshi, additional, Terasaki, Tadashi, additional, Yamaguchi, Keiji, additional, Okubo, Seiji, additional, Ueno, Yuji, additional, Ohara, Nobuyuki, additional, Kamiya, Yuki, additional, Takeuchi, Masataka, additional, Yazawa, Yukako, additional, Terasawa, Yuka, additional, Doijiri, Ryosuke, additional, Tsuboi, Yoshifumi, additional, Sonoda, Kazutaka, additional, Nomura, Koichi, additional, Shimoyama, Takashi, additional, Kutsuna, Akihito, additional, and Kimura, Kazumi, additional

Published
2022
Full Text
View/download PDF

96. Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study

Author

Kimura, Shunsuke, primary, Toyoda, Kazunori, additional, Yoshimura, Sohei, additional, Minematsu, Kazuo, additional, Yasaka, Masahiro, additional, Paciaroni, Maurizio, additional, Werring, David J., additional, Yamagami, Hiroshi, additional, Nagao, Takehiko, additional, Yoshimura, Shinichi, additional, Polymeris, Alexandros, additional, Zietz, Annaelle, additional, Engelter, Stefan T., additional, Kallmünzer, Bernd, additional, Cappellari, Manuel, additional, Chiba, Tetsuya, additional, Yoshimoto, Takeshi, additional, Shiozawa, Masayuki, additional, Kitazono, Takanari, additional, Koga, Masatoshi, additional, Todo, Kenichi, additional, Kimura, Kazumi, additional, Yagita, Yoshiki, additional, Furui, Eisuke, additional, Itabashi, Ryo, additional, Terasaki, Tadashi, additional, Shiokawa, Yoshiaki, additional, Hirano, Teruyuki, additional, Kamiyama, Kenji, additional, Nakagawara, Jyoji, additional, Takizawa, Shunya, additional, Homma, Kazunari, additional, Okuda, Satoshi, additional, Okada, Yasushi, additional, Tokunaga, Keisuke, additional, Kameda, Tomoaki, additional, Kario, Kazuomi, additional, Nagakane, Yoshinari, additional, Hasegawa, Yasuhiro, additional, Akiyama, Hisanao, additional, Shibuya, Satoshi, additional, Mochizuki, Hiroshi, additional, Ito, Yasuhiro, additional, Nakashima, Takahiro, additional, Matsuoka, Hideki, additional, Takamatsu, Kazuhiro, additional, Nishiyama, Kazutoshi, additional, Sato, Shoichiro, additional, Arihiro, Shoji, additional, Inoue, Manabu, additional, Takagi, Masahito, additional, Tanaka, Kanta, additional, Nagatsuka, Kazuyuki, additional, Yamaguchi, Takenori, additional, Hashimoto, Yoichiro, additional, Houkin, Kiyohiro, additional, Kitagawa, Kazuo, additional, Matsumoto, Masayasu, additional, Tanahashi, Norio, additional, Terayama, Yasuo, additional, Uchiyama, Shinichiro, additional, Mori, Etsuro, additional, Furukawa, Yutaka, additional, Kimura, Takeshi, additional, Kumon, Yoshiaki, additional, Nagata, Ken, additional, Nogawa, Shigeru, additional, Sakamoto, Tomohiro, additional, Hirai, Toshinori, additional, Kudo, Kohsuke, additional, Sasaki, Makoto, additional, Kobayashi, Shotai, additional, Hamasaki, Toshimitsu, additional, Giustozzi, Michela, additional, Acciarresi, Monica, additional, Agnelli, Giancarlo, additional, Caso, Valeria, additional, Bandini, Fabio, additional, Tsivgoulis, Georgios, additional, Yaghi, Shadi, additional, Furie, Karen L., additional, Tadi, Prasanna, additional, Becattini, Cecilia, additional, Zedde, Marialuisa, additional, Abdul-Rahim, Azmil H, additional, Lees, Kennedy R, additional, Alberti, Andrea, additional, Venti, Michele, additional, D’Amore, Cataldo, additional, Giulia Mosconi, Maria, additional, Anna Cimini, Ludovica, additional, Bovi, Paolo, additional, Carletti, Monica, additional, Rigatelli, Alberto, additional, Putaala, Jukka, additional, Tomppo, Liisa, additional, Tatlisumak, Turgut, additional, Marcheselli, Simona, additional, Pezzini, Alessandro, additional, Poli, Loris, additional, Padovani, Alessandro, additional, Vannucchi, Vieri, additional, Sohn, Sung-Il, additional, Lorenzini, Gianni, additional, Tassi, Rossana, additional, Guideri, Francesca, additional, Acampa, Maurizio, additional, Martini, Giuseppe, additional, Ntaios, George, additional, Athanasakis, George, additional, Makaritsis, Konstantinos, additional, Karagkiozi, Efstathia, additional, Vadikolias, Konstantinos, additional, Liantinioti, Chrissoula, additional, Chondrogianni, Maria, additional, Mumoli, Nicola, additional, Galati, Franco, additional, Sacco, Simona, additional, Tiseo, Cindy, additional, Corea, Francesco, additional, Ageno, Walter, additional, Bellesini, Marta, additional, Colombo, Giovanna, additional, Silvestrelli, Giorgio, additional, Ciccone, Alfonso, additional, Lanari, Alessia, additional, Scoditti, Umberto, additional, Denti, Licia, additional, Mancuso, Michelangelo, additional, Maccarrone, Miriam, additional, Ulivi, Leonardo, additional, Orlandi, Giovanni, additional, Giannini, Nicola, additional, Tassinari, Tiziana, additional, De Lodovici, Maria Luisa, additional, Rueckert, Christina, additional, Baldi, Antonio, additional, Toni, Danilo, additional, Letteri, Federica, additional, Giuntini, Martina, additional, Lotti, Enrico Maria, additional, Flomin, Yuriy, additional, Pieroni, Alessio, additional, Kargiotis, Odysseas, additional, Karapanayiotides, Theodore, additional, Monaco, Serena, additional, Baronello, Mario Maimone, additional, Csiba, Laszló, additional, Szabó, Lilla, additional, Chiti, Alberto, additional, Giorli, Elisa, additional, Del Sette, Massimo, additional, Imberti, Davide, additional, Zabzuni, Dorjan, additional, Doronin, Boris, additional, Volodina, Vera, additional, Michel, Patrik, additional, Vanacker, Peter, additional, Barlinn, Kristian, additional, Pallesen, Lars-Peder, additional, Barlinn, Jessica, additional, Deleu, Dirk, additional, Melikyan, Gayane, additional, Ibrahim, Faisal, additional, Akhtar, Naveed, additional, Gourbali, Vanessa, additional, Masotti, Luca, additional, Parry-Jones, Adrian, additional, Patterson, Chris, additional, Price, Christopher, additional, Elmarimi, Abduelbaset, additional, Parry, Anthea, additional, Nallasivam, Arumug, additional, Mohd Nor, Azlisham, additional, Esis, Bernard, additional, Bruce, David, additional, Roffe, Christine, additional, Holmes, Clare, additional, Cohen, David, additional, Hargroves, David, additional, Mangion, David, additional, Chadha, Dinesh, additional, Vahidassr, Djamil, additional, Manawadu, Dulka, additional, Giallombardo, Elio, additional, Warburton, Elizabeth, additional, Flossman, Enrico, additional, Gunathilagan, Gunaratam, additional, Proschel, Harald, additional, Emsley, Hedley, additional, Anwar, Ijaz, additional, Okwera, James, additional, Putterill, Janet, additional, O’Connell, Janice, additional, Bamford, John, additional, Corrigan, John, additional, Scott, Jon, additional, Birns, Jonathan, additional, Kee, Karen, additional, Saastamoinen, Kari, additional, Pasco, Kath, additional, Dani, Krishna, additional, Sekaran, Lakshmanan, additional, Choy, Lillian, additional, Iveson, Liz, additional, Mamun, Maam, additional, Sajid, Mahmud, additional, Cooper, Martin, additional, Burn, Matthew, additional, Smith, Matthew, additional, Power, Michael, additional, Davis, Michelle, additional, Smyth, Nigel, additional, Veltkamp, Roland, additional, Sharma, Pankaj, additional, Guyler, Paul, additional, O’Mahony, Paul, additional, Wilkinson, Peter, additional, Datta, Prabel, additional, Aghoram, Prasanna, additional, Marsh, Rachel, additional, Luder, Robert, additional, Meenakishundaram, Sanjeevikumar, additional, Subramonian, Santhosh, additional, Leach, Simon, additional, Ispoglou, Sissi, additional, Andole, Sreeman, additional, England, Timothy, additional, Manoj, Aravindakshan, additional, Harrington, Frances, additional, Rehman, Habib, additional, Sword, Jane, additional, Staals, Julie, additional, Mahawish, Karim, additional, Harkness, Kirsty, additional, Shaw, Louise, additional, McCormich, Michael, additional, Sprigg, Nikola, additional, Mansoor, Syed, additional, Krishnamurthy, Vinodh, additional, Lyrer, Philippe A, additional, Bonati, Leo H, additional, Seiffge, David J, additional, Traenka, Christopher, additional, Peters, Nils, additional, De Marchis, Gian Marco, additional, Thilemann, Sebastian, additional, Avramiotis, Nikolaos S, additional, Gensicke, Henrik, additional, Hert, Lisa, additional, Wagner, Benjamin, additional, Schaub, Fabian, additional, Meya, Louisa, additional, Fladt, Joachim, additional, Dittrich, Tolga, additional, Fisch, Urs, additional, Bonetti, Bruno, additional, Tomelleri, Giampaolo, additional, Micheletti, Nicola, additional, Zivelonghi, Cecilia, additional, Emiliani, Andrea, additional, Macha, Kosmas, additional, Siedler, Gabriela, additional, Stoll, Svenja, additional, Wang, Ruihao, additional, Volbers, Bastian, additional, Schwab, Stefan, additional, Haupenthal, David, additional, and Gaßmann, Luise, additional

Published
2022
Full Text
View/download PDF

100. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke

Author

Toyoda, Kazunori, primary, Omae, Katsuhiro, additional, Hoshino, Haruhiko, additional, Uchiyama, Shinichiro, additional, Kimura, Kazumi, additional, Miwa, Kaori, additional, Minematsu, Kazuo, additional, Yamaguchi, Keiji, additional, Suda, Yoshitaka, additional, Toru, Shuta, additional, Kitagawa, Kazuo, additional, Ihara, Masafumi, additional, Koga, Masatoshi, additional, and Yamaguchi, Takenori, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results